Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hamer

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bone & Joint Open|July 31, 2023
Financial analysis of revision hip surgery at a tertiary referral centre as classified using the British Hip Society Revision Hip Complexity ClassificationDavid I Hillier, Michael J Petrie, Tim P Harrison, et al.
American Heart Journal|March 20, 2012
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyAndrew Tonkin, David Hunt, Merryn Voysey, et al.
The New Zealand Medical Journal|December 24, 2013
The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional careChris Ellis, Greg Gamble, Gerard Devlin, et al.
European Heart Journal|June 2, 2010
Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosisRalph A H Stewart, Andrew J Kerr, Gillian A Whalley, et al.
The New Zealand Medical Journal|April 7, 2017
A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012John M Elliott, Tom Kai Ming Wang, Greg D Gamble, et al.
Journal of the American College of Cardiology|November 16, 2020
Effect of Evolocumab on Complex Coronary Disease Requiring RevascularizationKazuma Oyama, Remo H M Furtado, Antonio Fagundes, et al.
Journal of Clinical Lipidology|October 9, 2022
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemiaDaniel Gaudet, Andrea Ruzza, Ian Bridges, et al.
Circulation. Cardiovascular Interventions|February 25, 2022
Effect of Evolocumab in Patients With Prior Percutaneous Coronary InterventionRemo H M Furtado, Antônio Aurélio Fagundes, Kazuma Oyama, et al.
Journal of the American College of Cardiology|August 25, 2022
Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER TrialAntonio Fagundes, David A Morrow, Kazuma Oyama, et al.
ESC Heart Failure|February 19, 2026
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER studyDennis M McNamara, Leslie T Cooper, Matthias G Friedrich, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bone & Joint Open|July 31, 2023
Financial analysis of revision hip surgery at a tertiary referral centre as classified using the British Hip Society Revision Hip Complexity ClassificationDavid I Hillier, Michael J Petrie, Tim P Harrison, et al.
American Heart Journal|March 20, 2012
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyAndrew Tonkin, David Hunt, Merryn Voysey, et al.
The New Zealand Medical Journal|December 24, 2013
The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional careChris Ellis, Greg Gamble, Gerard Devlin, et al.
European Heart Journal|June 2, 2010
Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosisRalph A H Stewart, Andrew J Kerr, Gillian A Whalley, et al.
The New Zealand Medical Journal|April 7, 2017
A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012John M Elliott, Tom Kai Ming Wang, Greg D Gamble, et al.
Journal of the American College of Cardiology|November 16, 2020
Effect of Evolocumab on Complex Coronary Disease Requiring RevascularizationKazuma Oyama, Remo H M Furtado, Antonio Fagundes, et al.
Journal of Clinical Lipidology|October 9, 2022
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemiaDaniel Gaudet, Andrea Ruzza, Ian Bridges, et al.
Circulation. Cardiovascular Interventions|February 25, 2022
Effect of Evolocumab in Patients With Prior Percutaneous Coronary InterventionRemo H M Furtado, Antônio Aurélio Fagundes, Kazuma Oyama, et al.
Journal of the American College of Cardiology|August 25, 2022
Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER TrialAntonio Fagundes, David A Morrow, Kazuma Oyama, et al.
ESC Heart Failure|February 19, 2026
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER studyDennis M McNamara, Leslie T Cooper, Matthias G Friedrich, et al.
Pageof 3